{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T14:40:26Z","timestamp":1748184026753},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,24]]},"DOI":"10.7759\/cureus.63060","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T22:24:55Z","timestamp":1719267895000},"source":"Crossref","is-referenced-by-count":1,"title":["Trichoblastic Carcinoma in the Glabella Treated With Mohs Micrographic Surgery"],"prefix":"10.7759","author":[{"given":"Lily","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Crasto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelby L","family":"Kubicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rivlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000142240.93956.cb","article-title":"High-grade trichoblastic carcinoma arising in trichoblastoma: a rare adnexal neoplasm often showing metastatic spread","volume":"27","author":"Schulz T","year":"2005","unstructured":"Schulz T, Proske S, Hartschuh W, Kurzen H, Paul E, W\u00fcnsch PH. High-grade trichoblastic carcinoma arising in trichoblastoma: a rare adnexal neoplasm often showing metastatic spread. Am J Dermatopathol. 2005, 27:9-16. 10.1097\/01.dad.0000142240.93956.cb","journal-title":"Am J Dermatopathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7181\/acfs.2018.02124","article-title":"A giant trichoblastic carcinoma","volume":"19","author":"Lee JS","year":"2018","unstructured":"Lee JS, Kwon JH, Jung GS, et al.. A giant trichoblastic carcinoma. Arch Craniofac Surg. 2018, 19:275-8. 10.7181\/acfs.2018.02124","journal-title":"Arch Craniofac Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0322","article-title":"Malignant transformation of multiple familial trichoepithelioma: case report and literature review","volume":"88","author":"Lee KH","year":"2008","unstructured":"Lee KH, Kim JE, Cho BK, Kim YC, Park CJ. Malignant transformation of multiple familial trichoepithelioma: case report and literature review. Acta Derm Venereol. 2008, 88:43-6. 10.2340\/00015555-0322","journal-title":"Acta Derm Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_639_17","article-title":"Trichoblastic carcinoma arising in trichoepithelioma in Brooke-Spiegler syndrome","volume":"62","author":"Leelamma JP","year":"2019","unstructured":"Leelamma JP, Sundaram S, Kandasamy S. Trichoblastic carcinoma arising in trichoepithelioma in Brooke-Spiegler syndrome. Indian J Pathol Microbiol. 2019, 62:313-8. 10.4103\/IJPM.IJPM_639_17","journal-title":"Indian J Pathol Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02241-y","article-title":"Trichoblastic carcinoma: a comprehensive review of the literature","volume":"314","author":"Boettler MA","year":"2022","unstructured":"Boettler MA, Shahwan KT, Abidi NY, Carr DR. Trichoblastic carcinoma: a comprehensive review of the literature. Arch Dermatol Res. 2022, 314:399-403. 10.1007\/s00403-021-02241-y","journal-title":"Arch Dermatol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14686","article-title":"High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKT","volume":"46","author":"Fusumae T","year":"2019","unstructured":"Fusumae T, Tanese K, Takeuchi A, Takasugi A, Kawakita R, Shiraishi J, Yoshida T. High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKT. J Dermatol. 2019, 46:57-60. 10.1111\/1346-8138.14686","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb14841.x","article-title":"Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer","volume":"127","author":"McGregor JM","year":"1992","unstructured":"McGregor JM, Yu CC, Dublin EA, Levison DA, MacDonald DM. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br J Dermatol. 1992, 127:463-9. 10.1111\/j.1365-2133.1992.tb14841.x","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/cup.13892","article-title":"Trichoblastic carcinosarcoma in a 34-year-old woman with histopathologic and molecular analysis, including re-demonstration of a CDKN2A p.(R58*) mutation","volume":"48","author":"Kim C","year":"2021","unstructured":"Kim C, Brown A, Osipov V. Trichoblastic carcinosarcoma in a 34-year-old woman with histopathologic and molecular analysis, including re-demonstration of a CDKN2A p.(R58*) mutation. J Cutan Pathol. 2021, 48:334-9. 10.1111\/cup.13892","journal-title":"J Cutan Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880118","article-title":"Trichoblastic carcinoma (\"malignant trichoblastoma\") with lymphatic and hematogenous metastases","volume":"13","author":"Regauer S","year":"2000","unstructured":"Regauer S, Beham-Schmid C, Okcu M, Hartner E, Mannweiler S. Trichoblastic carcinoma (\"malignant trichoblastoma\") with lymphatic and hematogenous metastases. Mod Pathol. 2000, 13:673-8. 10.1038\/modpathol.3880118","journal-title":"Mod Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anplas.2017.03.001","article-title":"[Why is it important to differentiate trichoblastic carcinomas (CT) from basal cell carcinomas (CBC). About 21 cases]","volume":"62","author":"Thomas M","year":"2017","unstructured":"Thomas M, Bruant-Rodier C, Bodin F, Cribier B, Huther M, Dissaux C. [Why is it important to differentiate trichoblastic carcinomas (CT) from basal cell carcinomas (CBC). About 21 cases]. Ann Chir Plast Esthet. 2017, 62:212-8. 10.1016\/j.anplas.2017.03.001","journal-title":"Ann Chir Plast Esthet"},{"key":"ref11","article-title":"Neoplasms with follicular differentiation","author":"Ackerman AB","year":"2001","unstructured":"Ackerman AB, Reddy VB, Soyer HP. Neoplasms with follicular differentiation. Ardor Scribendi, New York; 2001."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2012.02537.x","article-title":"Trichoblastic carcinoma associated with multiple familial trichoepithelioma","volume":"38","author":"Kirby JS","year":"2012","unstructured":"Kirby JS, Siebert Lucking SM, Billingsley EM. Trichoblastic carcinoma associated with multiple familial trichoepithelioma. Dermatol Surg. 2012, 38:2018-21. 10.1111\/j.1524-4725.2012.02537.x","journal-title":"Dermatol Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e31815c6c7f","article-title":"High-grade trichoblastic carcinosarcoma","volume":"30","author":"Kazakov DV","year":"2008","unstructured":"Kazakov DV, Vittay G, Michal M, Calonje E. High-grade trichoblastic carcinosarcoma. Am J Dermatopathol. 2008, 30:62-4. 10.1097\/DAD.0b013e31815c6c7f","journal-title":"Am J Dermatopathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5070\/D3249041416","article-title":"A trichogenic tumor with aggressive features initially diagnosed as basal cell carcinoma","volume":"24","author":"Kwock JT","year":"2018","unstructured":"Kwock JT, Casady M, Handfield C, MacLeod AS, Pavlis MB. A trichogenic tumor with aggressive features initially diagnosed as basal cell carcinoma. Dermatol Online J. 2018, 24:1-4. 10.5070\/D3249041416","journal-title":"Dermatol Online J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2019.09.595","article-title":"[Giant trichoblastic carcinoma: 3\u00a0cases]","volume":"146","author":"Berniolles P","year":"2019","unstructured":"Berniolles P, Okhremchuk I, Valois A, et al.. [Giant trichoblastic carcinoma: 3\u00a0cases]. Ann Dermatol Venereol. 2019, 146:828-31. 10.1016\/j.annder.2019.09.595","journal-title":"Ann Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2678","article-title":"Locally aggressive trichoblastic tumours (low-grade trichoblastic carcinomas): clinicopathological analysis and follow-up","volume":"98","author":"Hua C","year":"2018","unstructured":"Hua C, Velter C, Osio A, Lebbe C, Basset-Seguin N, Cribier B, Battistella M. Locally aggressive trichoblastic tumours (low-grade trichoblastic carcinomas): clinicopathological analysis and follow-up. Acta Derm Venereol. 2018, 98:126-7. 10.2340\/00015555-2678","journal-title":"Acta Derm Venereol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13919","article-title":"Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma","volume":"173","author":"Lepesant P","year":"2015","unstructured":"Lepesant P, Crinquette M, Alkeraye S, Mirabel X, Dziwniel V, Cribier B, Mortier L. Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma. Br J Dermatol. 2015, 173:1059-62. 10.1111\/bjd.13919","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14366\/usg.22130","article-title":"Top applications of dermatologic ultrasonography that can modify management","volume":"42","author":"Wortsman X","year":"2023","unstructured":"Wortsman X. Top applications of dermatologic ultrasonography that can modify management. Ultrasonography. 2023, 42:183-202. 10.14366\/usg.22130","journal-title":"Ultrasonography"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18309","article-title":"Formalin-fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma","volume":"36","author":"Gonzalez-Lara L","year":"2022","unstructured":"Gonzalez-Lara L, Bonsang B, Zimmermann U, et al.. Formalin-fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma. J Eur Acad Dermatol Venereol. 2022, 36:e827-8. 10.1111\/jdv.18309","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03301.x","article-title":"Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: report of two patients with hidradenocarcinoma and trichoblastic carcinoma","volume":"24","author":"Battistella M","year":"2010","unstructured":"Battistella M, Mateus C, Lassau N, et al.. Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: report of two patients with hidradenocarcinoma and trichoblastic carcinoma. J Eur Acad Dermatol Venereol. 2010, 24:199-203. 10.1111\/j.1468-3083.2009.03301.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14389","article-title":"Hedgehog pathway mutations are involved in the pathogenesis of plaque-type \"trichoblastoma\": a report of two cases","volume":"50","author":"Giang J","year":"2023","unstructured":"Giang J, Mooyaart AL, Martens-de Kemp SR, et al.. Hedgehog pathway mutations are involved in the pathogenesis of plaque-type \"trichoblastoma\": a report of two cases. J Cutan Pathol. 2023, 50:674-80. 10.1111\/cup.14389","journal-title":"J Cutan Pathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.05.024","article-title":"Vismodegib efficacy in unresectable trichoblastic carcinoma: a multicenter study of 16 cases","volume":"86","author":"Duplaine A","year":"2022","unstructured":"Duplaine A, Beylot-Barry M, Mansard S, et al.. Vismodegib efficacy in unresectable trichoblastic carcinoma: a multicenter study of 16 cases. J Am Acad Dermatol. 2022, 86:1365-6. 10.1016\/j.jaad.2021.05.024","journal-title":"J Am Acad Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03449-9","article-title":"Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas","volume":"72","author":"Toulemonde E","year":"2023","unstructured":"Toulemonde E, Chevret S, Battistella M, et al.. Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas. Cancer Immunol Immunother. 2023, 72:2649-57. 10.1007\/s00262-023-03449-9","journal-title":"Cancer Immunol Immunother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/205072-trichoblastic-carcinoma-in-the-glabella-treated-with-mohs-micrographic-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T22:24:59Z","timestamp":1719267899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/205072-trichoblastic-carcinoma-in-the-glabella-treated-with-mohs-micrographic-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.63060","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,24]]}}}